CLIA Kit for Apolipoprotein B100 (APOB100)

Apo-B100

Specificity

This assay has high sensitivity and excellent specificity for detection of Apolipoprotein B100 (APOB100).
No significant cross-reactivity or interference between Apolipoprotein B100 (APOB100) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Apolipoprotein B100 (APOB100) and the recovery rates were calculated by comparing the measured value to the expected amount of Apolipoprotein B100 (APOB100) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 89-103 99
EDTA plasma(n=5) 99-105 102
heparin plasma(n=5) 80-103 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Apolipoprotein B100 (APOB100) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Apolipoprotein B100 (APOB100) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Apolipoprotein B100 (APOB100) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-98% 90-97% 84-102% 95-102%
EDTA plasma(n=5) 80-99% 95-102% 81-88% 95-105%
heparin plasma(n=5) 91-99% 90-104% 83-97% 88-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropoyl-β-Cyclodextrin Plosone: 0018033
Autonomic Neuroscience Chemical sympathectomy induces arterial accumulation of native and oxidized LDL in hypercholesterolemic rats ScienceDirect: S1566070211004152
Toxicology iTRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure ScienceDirect: S0300483X11004628
Atherosclerosis Up-reCavia (Guinea pig )lation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations Pubmed:26978583
Proteomics Clinical Applications Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients Pubmed:26680509
molecular nutrition & food research Alleviating VLDL overproduction is an important mechanism for Laminaria japonica polysaccharide to inhibit atherosclerosis in LDLr-/- mice with diet-induced insulin resistance. pubmed:27928899
PROTEOMICS - Clinical Applications Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients. pubmed:26680509
Biosci Biotechnol Biochem.  Choline and betaine ameliorate liver lipid accumulation induced by vitamin B6 deficiency in rats. pubmed:27696964
Journal of Nutritional Science and Vitaminology Accumulation of Liver Lipids Induced by Vitamin B6 Deficiency Was Effectively Ameliorated by Choline and, to a Lesser Extent, Betaine Pubmed: 30814419
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY Zygophyllum album saponins prevent atherogenic effect induced by deltamethrin via attenuating arterial accumulation of native and oxidized LDL in rats Pubmed: 32105945
Ecotoxicol Environ Saf Permethrin induced arterial retention of native and oxidized LDL in rats by promoting inflammation, oxidative stress and affecting LDL receptors, and collagen … Pubmed: 32911180
Nat Commun GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity 34853313
Clinical Nutrition Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or Type 2 diabetes 34656950
Nano Research Immunomodulatory hybrid bio-nanovesicle for self-promoted photodynamic therapy
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
NPA603Hu01 Native Apolipoprotein B100 (APOB100) Positive Control; Immunogen; SDS-PAGE; WB.
RPA603Hu01 Recombinant Apolipoprotein B100 (APOB100) Positive Control; Immunogen; SDS-PAGE; WB.
PAA603Hu01 Polyclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
PAA603Hu02 Polyclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
LAA603Hu71 Biotin-Linked Polyclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC.
MAA603Hu23 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu24 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu25 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu29 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu27 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu21 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
MAA603Hu22 Monoclonal Antibody to Apolipoprotein B100 (APOB100) WB; IHC; ICC; IP.
SEA603Hu ELISA Kit for Apolipoprotein B100 (APOB100) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA603Hu CLIA Kit for Apolipoprotein B100 (APOB100) Chemiluminescent immunoassay for Antigen Detection.
LMA603Hu Multiplex Assay Kit for Apolipoprotein B100 (APOB100) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.